Saeki Issei 佐伯一成

Researcher Number	60634756
Other IDs	https://orcid.org/0000-0001-5885-5042
Affiliation (Current)	2024: 山口大学, 医学部附属病院, 講師
Affiliation (based on the past Project Information) *help	2021 – 2024: 山口大学, 医学部附属病院, 講師 2016 – 2020: 山口大学, 医学部附属病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related Except Principal Investigator Basic Section 52010:General internal medicine-related / Basic Section 53010:Gastroenterology-related / Basic Section 59040:Nutrition science and health science-related / Gastroenterology
Keywords	Principal Investigator 進行肝細胞癌 / 腫瘍マーカー / リキッドバイオプシー / 肝細胞癌 Except Principal Investigator 肝細胞癌 / リキッドバイオプシー / 診断 / 肝癌 / SEPT9 / メチル化 … More / 生活習慣病 / 非B非C型肝癌 / 細胞外小胞 / 肝がん / 癌 / deferoxamine / deferasirox / 鉄キレート剤 / 膵癌 Less

早期肝癌発見を可能とするリキッドバイオプシー検査体制の構築
- Principal Investigator
  
  山崎隆弘
- Project Period (FY)
  2023 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 52010:General internal medicine-related
- Research Institution
  Yamaguchi University
Establishment of a Novel Screening Test for Diagnosing Hepatocellular Carcinoma based on a Sensitive DNA Methylation Assay
- Principal Investigator
  
  Yamasaki Takahiro
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Yamaguchi University
生活習慣病に合併する肝癌の早期診断マーカーの開発：血中細胞外小胞の解析
- Principal Investigator
  
  山口奈津
- Project Period (FY)
  2019 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 59040:Nutrition science and health science-related
- Research Institution
  Yamaguchi University
Challenging for the management of HCC using novel liquid biopsy testPrincipal Investigator
- Principal Investigator
  
  Saeki Issei
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Yamaguchi University
Effects of a novel oral iron chelator on refractory digestive system cancers
- Principal Investigator
  
  YAMASAKI Takahiro
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Gastroenterology
- Research Institution
  Yamaguchi University

All 2023 2022 2021 2020 2019 2018 2017 2016 2015

All Journal Article Presentation

[Journal Article] Double cancer of primary hepatic angiosarcoma and hepatocellular carcinoma treated with atezolizumab plus bevacizumab. Hepatol Res. 2023 Feb 24.2023
- Author(s)
  Yamauchi Y, Saeki I, Yamasaki T, Egusa M, Nishiyama N, Fujioka T, Kawamoto D, Nishimura T, Tanabe N, Oono T, Matsumoto T, Ishikawa T, Marumoto Y, Matsukuma S, Shindo Y, Tokumitsu Y, Yoshimine S, Murakami J, Tanaka T, Kimura S, Hoshii Y, Hamano K, Nagano H, Takami T.
- Journal Title
  
  Hepatol Res.
  
  Volume: - Issue: 7 Pages: 681-686
- DOI
  10.1111/hepr.13894
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08358, KAKENHI-PROJECT-19K17463
[Journal Article] Impact of skeletal muscle volume on patients with BCLC stage-B hepatocellular carcinoma undergoing sorafenib therapy2023
- Author(s)
  Saeki I, Yamasaki T, Yamauchi Y, Kawaoka T, Uchikawa S, Hiramatsu A, Aikata H, Kobayashi K, Kondo T, Ogasawara S, Chiba T, Kawano R, Chayama K, Kato N, Takami T.
- Journal Title
  
  Cancer Med.
  
  Volume: - Issue: 9 Pages: 10625-10635
- DOI
  10.1002/cam4.5810
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08332, KAKENHI-PROJECT-19K17463
[Journal Article] Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment2022
- Author(s)
  Yamasaki T, Saeki I, Yamauchi Y, Matsumoto T, Suehiro Y, Kawaoka T, Uchikawa S, Hiramatsu A, Aikata H, Kobayashi K, Kondo T, Ogasawara S, Chiba T, Takami T, Chayama K, Kato N, Sakaida I.
- Journal Title
  
  Liver Cancer.
  
  Volume: 11 Issue: 4 Pages: 329-340
- DOI
  10.1159/000522389
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08332
[Journal Article] A combination of liver stiffness and international normalized ratio is an ideal prognostic predictor of portosystemic shunt occlusion in patients with portal hypertension2022
- Author(s)
  Ishikawa Tsuyoshi、Egusa Maho、Fujioka Tsuyoshi、Nishiyama Natsuko、Kawamoto Daiki、Sasaki Ryo、Nishimura Tatsuro、Tanabe Norikazu、Oono Takashi、Saeki Issei、Takami Taro
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: 58 Issue: 3 Pages: 246-256
- DOI
  10.1007/s00535-022-01947-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08137, KAKENHI-PROJECT-20K08358, KAKENHI-PROJECT-19K17463
[Journal Article] Screening for portopulmonary hypertension using computed tomography-based measurements of the main pulmonary artery and ascending aorta diameters in patients with portal hypertension.2022
- Author(s)
  Ishikawa T, Egusa M, Kawamoto D, Nishimura T, Sasaki R, Saeki I, Sakaida I, Takami T.
- Journal Title
  
  Hepatol Res.
  
  Volume: 52(3) Issue: 3 Pages: 255-268
- DOI
  10.1111/hepr.13735
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08358, KAKENHI-PROJECT-19K17463
[Journal Article] Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification2021
- Author(s)
  Ishikawa Tsuyoshi、Sasaki Ryo、Nishimura Tatsuro、Matsuda Takashi、Iwamoto Takuya、Saeki Issei、Hidaka Isao、Takami Taro、Sakaida Isao
- Journal Title
  
  Intern. Med.
  
  Volume: 60 Issue: 9 Pages: 1331-1342
- DOI
  10.2169/internalmedicine.6267-20
- NAID
  130008033267
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2021-05-01
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10441, KAKENHI-PROJECT-20K08137, KAKENHI-PROJECT-19K17463
[Journal Article] Successful Management With Dual Therapy of Lenvatinib and Macitentan for HCC With Portopulmonary Hypertension2021
- Author(s)
  Ishikawa Tsuyoshi、Sasaki Ryo、Matsuda Takashi、Saeki Issei、Takami Taro、Wada Yasuaki、Yano Masafumi、Sakaida Isao
- Journal Title
  
  Hepatology
  
  Volume: 74 Issue: 4 Pages: 2300-2303
- DOI
  10.1002/hep.31865
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08137, KAKENHI-PROJECT-20K08358, KAKENHI-PROJECT-19K17463
[Journal Article] 高感度DNAメチル化解析技術を用いたリキッドバイオプシーによる肝細胞癌スクリーニング : メチル化SSTとメチル化SEPT9の診断性能比較2021
- Author(s)
  山﨑綾乃、末廣寛、星田朋美、佐伯一成、山内（厚東）由里佳、松本俊彦、高見太郎、坂井田功、山﨑隆弘
- Journal Title
  
  山口医学
  
  Volume: 70 Pages: 89-98
- NAID
  130008132582
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08332
[Journal Article] Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenism2021
- Author(s)
  Ishikawa Tsuyoshi、Sasaki Ryo、Nishimura Tatsuro、Matsuda Takashi、Iwamoto Takuya、Saeki Issei、Hidaka Isao、Takami Taro、Sakaida Isao
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: 56 Issue: 4 Pages: 382-394
- DOI
  10.1007/s00535-021-01762-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10441, KAKENHI-PROJECT-20K08137, KAKENHI-PROJECT-20K08358, KAKENHI-PROJECT-19K17463
[Journal Article] 臨床検査技師を含む多職種連携による院内肝炎ウイルス検査陽性者受診勧奨の取り組み2021
- Author(s)
  日高勲 , 大野高嗣 , 藤永亜季 , 増井美由紀 , 久永拓郎 , 佐伯一成 , 松本俊彦 , 丸本芳雄 , 石川剛 , 高見太郎 , 川野伶緒 , 山﨑隆弘 , 坂井田功
- Journal Title
  
  肝臓
  
  Volume: 62 Pages: 448-455
- NAID
  130008072666
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08332
[Journal Article] Clinical Benefits of Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma.2021
- Author(s)
  Yamasaki T, Saeki I, Kotoh-Yamauchi Y, Sasaki R, Tanabe N, OonoT, Matsuda T, Takuro Hisanaga T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Suehiro Y, Sakaida I.
- Journal Title
  
  Applied Sciences(Basel)
  
  Volume: 11 Pages: 1882-1882
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08332
[Journal Article] Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma2021
- Author(s)
  Saeki Issei、Yamasaki Takahiro、Yamauchi Yurika、Takami Taro、Kawaoka Tomokazu、Uchikawa Shinsuke、Hiramatsu Akira、Aikata Hiroshi、Kawano Reo、Kobayashi Kazufumi、Kondo Takayuki、Ogasawara Sadahisa、Chiba Tetsuhiro、Chayama Kazuaki、Kato Naoya、Sakaida Isao
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 9 Pages: 2247-2247
- DOI
  10.3390/cancers13092247
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08332, KAKENHI-PROJECT-20K08358, KAKENHI-PROJECT-19K17463
[Journal Article] Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment2020
- Author(s)
  Saeki Issei、Yamasaki Takahiro、et al.
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 4 Pages: 779-779
- DOI
  10.3390/cancers12040779
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17463
[Journal Article] Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma. Hepatol Commun2020
- Author(s)
  Kotoh Y, Suehiro Y, Saeki I, Hoshida T, Maeda M, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Higaki S, Fujii I, Suzuki C, Shindo Y, Tokumitsu Y, Nagano H, Sakaida I, Yamasaki T
- Journal Title
  
  Hepatol Commun
  
  Volume: 4(3) Issue: 3 Pages: 461-470
- DOI
  10.1002/hep4.1469
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08646, KAKENHI-PROJECT-19K17463
[Journal Article] Clinical Benefits of Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma2020
- Author(s)
  Takahiro Yamasaki, Issei Saeki, Yurika Kotoh-Yamauchi, Ryo Sasaki, Norikazu Tanabe, Takashi Oono, Takashi Matsuda, Takuro Hisanaga, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Yutaka Suehiro, Isao Sakaida
- Journal Title
  
  applied sciences
  
  Volume: 11 Issue: 4 Pages: 1882-1882
- DOI
  10.3390/app11041882
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17463
[Journal Article] Effect of Handgrip Strength on Clinical Outcomes of Patients with Hepatocellular Carcinoma Treated with Lenvatinib2020
- Author(s)
  Yurika Kotoh, Issei Saeki, Takahiro Yamasaki, Ryo Sasaki, Norikazu Tanabe, Takashi Oono, Takashi Matsuda, Takuro Hisanaga, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Isao Sakaida
- Journal Title
  
  applied sciences
  
  Volume: 10 Issue: 16 Pages: 5403-5403
- DOI
  10.3390/app10165403
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17463
[Journal Article] Effect of Handgrip Strength on Clinical Outcomes of Patients with Hepatocellular Carcinoma Treated with Lenvatinib.2020
- Author(s)
  Kotoh Y, Saeki I, Yamasaki T, Sasaki R, Tanabe N, Oono T, Matsuda T, Hisanaga T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I.
- Journal Title
  
  Applied Sciences(Basel)
  
  Volume: 10 Pages: 5403-5403
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08332
[Journal Article] Blood Free-Circulating DNA Testing of Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer2020
- Author(s)
  Hideura Eizaburou、Suehiro Yutaka、Nishikawa Jun、Shuto Takuya、Fujimura Hiroyuki、Ito Shunsuke、Goto Atsushi、Hamabe Kouichi、Saeki Issei、Okamoto Takeshi、Higaki Shingo、Fujii Ikuei、Suzuki Chieko、Hoshida Tomomi、Matsumoto Toshihiko、Takami Taro、Sakaida Isao、Yamasaki Takahiro
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 4 Pages: 789-789
- DOI
  10.3390/cancers12040789
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17463
[Journal Article] Albumin-bilirubin score as a useful predictor of energy malnutrition in patients with hepatocellular carcinoma2020
- Author(s)
  Kotoh Yurika、Saeki Issei、Yamasaki Takahiro、Sasaki Ryo、Tanabe Norikazu、Oono Takashi、Maeda Masaki、Hidaka Isao、Ishikawa Tsuyoshi、Takami Taro、Sakaida Isao
- Journal Title
  
  Clinical Nutrition
  
  Volume: - Issue: 5 Pages: 3585-3591
- DOI
  10.1016/j.clnu.2020.12.023
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08332, KAKENHI-PROJECT-19K17463, KAKENHI-PROJECT-20K08358
[Journal Article] Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.2019
- Author(s)
  Ishikawa T, Sasaki R, Nishimura T, Matsuda T, Maeda M, Iwamoto T, Saeki I, Hidaka I, Takami T, Sakaida I.
- Journal Title
  
  J Gastroenterol Hepatol.
  
  Volume: 34(1) Issue: 1 Pages: 215-223
- DOI
  10.1111/jgh.14410
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09428, KAKENHI-PROJECT-17K10441, KAKENHI-PROJECT-16H05287, KAKENHI-PROJECT-17H04162
[Journal Article] Evaluation of the Effects of Cultured Bone Marrow Mesenchymal Stem Cell Infusion on Hepatocarcinogenesis in Hepatocarcinogenic Mice With Liver Cirrhosis.2019
- Author(s)
  Matsuura K, Takami T, Maeda M, Hisanaga T, Fujisawa K, Saeki I, Matsumoto T, Hidaka I, Yamamoto N, Sakaida I.
- Journal Title
  
  Transplant Proc.
  
  Volume: 51(3) Issue: 3 Pages: 925-935
- DOI
  10.1016/j.transproceed.2019.03.011
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05287, KAKENHI-PROJECT-18K08005, KAKENHI-PROJECT-17H04162, KAKENHI-PROJECT-17K09428
[Journal Article] A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification2019
- Author(s)
  Ishikawa Tsuyoshi、Sasaki Ryo、Nishimura Tatsuro、Aibe Yuki、Saeki Issei、Iwamoto Takuya、Hidaka Isao、Takami Taro、Sakaida Isao
- Journal Title
  
  PLOS ONE
  
  Volume: 14 Issue: 9 Pages: e0223153-e0223153
- DOI
  10.1371/journal.pone.0223153
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10441, KAKENHI-PROJECT-19K17463
[Journal Article] Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients2019
- Author(s)
  Maeda Masaki、Saeki Issei、et al.
- Journal Title
  
  Liver Cancer
  
  Volume: 9 Issue: 1 Pages: 50-62
- DOI
  10.1159/000502744
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17463
[Journal Article] Usefulness of Adult Medaka Fish as a Model for the Evaluation of Alcoholic Fatty Liver.2019
- Author(s)
  Fujisawa K, Takami T, Nagatomo T, Fukui Y, Hoshida H, Saeki I, Matsumoto T, Hidaka I, Yamamoto N, Sakaida I.
- Journal Title
  
  Alcohol.
  
  Volume: 77 Pages: 147-154
- DOI
  10.1016/j.alcohol.2019.01.005
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09428, KAKENHI-PROJECT-16K19823, KAKENHI-PROJECT-16H05287, KAKENHI-PROJECT-17H04162, KAKENHI-PROJECT-18K15815
[Journal Article] Evaluation of the 'assessment for continuous treatment with hepatic arterial infusion chemotherapy' scoring system in patients with advanced hepatocellular carcinoma.2018
- Author(s)
  Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I.
- Journal Title
  
  Hepatol Res.
  
  Volume: 48(3) Issue: 3
- DOI
  10.1111/hepr.12932
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16H05287, KAKENHI-PROJECT-16K21193
[Journal Article] Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion.2018
- Author(s)
  Nishi M, Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I.
- Journal Title
  
  Hepatol Res.
  
  Volume: 48(4) Issue: 4 Pages: 329-332
- DOI
  10.1111/hepr.12995
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16H05287
[Journal Article] サルコペニアと肝細胞癌治療選択2018
- Author(s)
  佐伯一成, 山崎隆弘, 坂井田功
- Journal Title
  
  肝胆膵
  
  Volume: 77(4) Pages: 811-816
- Data Source
  KAKENHI-PROJECT-16H05287
[Journal Article] Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites.2018
- Author(s)
  Iwamoto T, Maeda M, Saeki I, Hidaka I, Tajima K, Ishikawa T, Takami T, Sakaida I.
- Journal Title
  
  J Gastroenterol Hepatol.
  
  Volume: - Issue: 7 Pages: 1231-1235
- DOI
  10.1111/jgh.14524
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09428, KAKENHI-PROJECT-17K15949, KAKENHI-PROJECT-16H05287, KAKENHI-PROJECT-17H04162
[Journal Article] Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy.2018
- Author(s)
  Saeki I, Yamasaki T, Maeda M, Hisanaga T, Iwamoto T, Fujisawa K, Matsumoto T, Hidaka I, Marumoto Y, Ishikawa T, Yamamoto N, Suehiro Y, Takami T, Sakaida I.
- Journal Title
  
  World J Hepatol.
  
  Volume: 10(9) Issue: 9 Pages: 571-584
- DOI
  10.4254/wjh.v10.i9.571
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09428, KAKENHI-PROJECT-18K08005, KAKENHI-PROJECT-18K15815, KAKENHI-PROJECT-16H05287, KAKENHI-PROJECT-17H04162
[Journal Article] Comparison of patients with hepatic encephalopathy and those with gastric varices before and after balloon-occluded retrograde transvenous obliteration.2018
- Author(s)
  Ishikawa T, Sasaki R, Nishimura T, Matsuda T, Maeda M, Iwamoto T, Saeki I, Hidaka I, Takami T, Sakaida I.
- Journal Title
  
  Hepatol Res.
  
  Volume: 48(12) Issue: 12 Pages: 1020-1030
- DOI
  10.1111/hepr.13199
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09428, KAKENHI-PROJECT-17K10441, KAKENHI-PROJECT-16H05287, KAKENHI-PROJECT-17H04162
[Journal Article] Outcomes following liver resection for multinodular Barcelona Clinic Liver Cancer?B hepatocellular carcinoma2018
- Author(s)
  Matsukuma Satoshi、Sakamoto Kazuhiko、Tokuhisa Yoshihiro、Tokumitsu Yukio、Matsui Hiroto、Kanekiyo Shinsuke、Tomochika Shinobu、Iida Michihisa、Suzuki Nobuaki、Takeda Shigeru、Ueno Tomio、Wada Hiroshi、Kobayashi Shogo、Saeki Issei、Eguchi Hidetoshi、Sakon Masato、Sakaida Isao、Nagano Hiroaki
- Journal Title
  
  Oncology Letters
  
  Volume: 16(5) Pages: 6383-6392
- DOI
  10.3892/ol.2018.9420
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08646, KAKENHI-PROJECT-16H05287
[Journal Article] III. 肝癌の治療動注化学療法2018
- Author(s)
  山﨑隆弘, 佐伯一成, 松本俊彦, 高見太郎, 坂井田　功
- Journal Title
  
  日本臨床
  
  Volume: 76(2) Pages: 240-246
- Data Source
  KAKENHI-PROJECT-16H05287
[Journal Article] 目で見る肝癌まれな画像所見を呈した巨大肝細胞癌の一例2018
- Author(s)
  佐伯一成, 山﨑隆弘, 前田雅喜, 田邉昌寛, 徳久善弘, 星井嘉信, 永野浩昭, 坂井田功
- Journal Title
  
  The liver cancer journal
  
  Volume: 10(1) Pages: 5-11
- NAID
  40021633578
- Data Source
  KAKENHI-PROJECT-16H05287
[Journal Article] No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma.2018
- Author(s)
  Saeki I, Yamasaki T, Maeda M, Kawano R, Hisanaga T, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I.
- Journal Title
  
  Liver Cancer.
  
  Volume: 7(4) Issue: 4 Pages: 359-371
- DOI
  10.1159/000487858
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09428, KAKENHI-PROJECT-16K19823, KAKENHI-PROJECT-16H05287, KAKENHI-PROJECT-17H04162
[Journal Article] 動注化学療法の新たな工夫－deferoxamineの効果－2017
- Author(s)
  山﨑隆弘, 佐伯一成, 藤澤浩一, 松本俊彦, 末廣　寛, 山本直樹, 高見太郎, 坂井田　功
- Journal Title
  
  肝胆膵
  
  Volume: 75(2) Pages: 374-382
- Data Source
  KAKENHI-PROJECT-16H05287
[Journal Article] 肝硬変患者に対する肝疾患専門医療機関の早期介入の有用性2017
- Author(s)
  久永拓郎、山﨑隆弘、前田雅喜、岩本拓也、佐伯一成、松本俊彦、日高　勲、丸本芳雄、石川　剛、高見太郎、坂井田　功
- Journal Title
  
  山口医学
  
  Volume: 66(3)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16H05287
[Journal Article] Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function2016
- Author(s)
  Takami T, Yamasaki T, Saeki I, Matsumoto M, Suehiro Y, Sakaida I.
- Journal Title
  
  World J Gastroenterol.
  
  Volume: 22（32） Issue: 32 Pages: 7252-63
- DOI
  10.3748/wjg.v22.i32.7252
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H05287, KAKENHI-PROJECT-26461009
[Journal Article] Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma2016
- Author(s)
  Saeki I, Yamamoto N, Yamasaki T(corresponding author), Takami T, Maeda M, Fujisawa K, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Uchida k, Tani K, Sakaida I
- Journal Title
  
  World J Gastroenterol.
  
  Volume: 22(40) Issue: 40 Pages: 8967-77
- DOI
  10.3748/wjg.v22.i40.8967
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H05287
[Journal Article] Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib2016
- Author(s)
  Yamamoto N, Yamasaki T, Takami T, Uchida K, Fujisawa K, Matsumoto T, Saeki I, Terai S, Sakaida I.
- Journal Title
  
  Journal of Clinical Biochemistry and Nutrition
  
  Volume: 58 Issue: 3 Pages: 202-209
- DOI
  10.3164/jcbn.15-127
- NAID
  130005149374
- ISSN
  0912-0009, 1880-5086
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H05287, KAKENHI-PROJECT-15K09005
[Journal Article] Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis.2016
- Author(s)
  Iwamoto T, Maeda M, Hisanaga T, Saeki I, Fujisawa K, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I.
- Journal Title
  
  Intern Med.
  
  Volume: 55(20) Pages: 2911-16
- NAID
  130005430015
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H05287
[Journal Article] Clinical characteristics and prognosis of non-B non-C hepatocellular carcinoma patients with modest alcohol consumption.2015
- Author(s)
  Urata Y, Yamasaki T, Saeki I, Iwai S, Kitahara M, Sawai Y, Tanaka K, Aoki T, Iwadou S, Fujita N, Nakayama Y, Maeshiro T, Takami T, Sakaida I.
- Journal Title
  
  Hepatol Res.
  
  Volume: - Issue: 5 Pages: 434-42
- DOI
  10.1111/hepr.12572
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26461009, KAKENHI-PROJECT-16H05287
[Presentation] Liquid biopsy test based on methylated-SEPT9 for diagnosis of hepatocellular carcinoma2022
- Author(s)
  Issei Saeki, Takahiro Yamasaki, Taro Takami
- Organizer
  JDDW 2022
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] メチル化SEPT9は肝細胞癌治療に対する分子標的治療薬の予後予測バイオマーカーとなる2022
- Author(s)
  佐伯一成, 山﨑隆弘, 高見太郎
- Organizer
  第58回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] Prognostic prediction by methylated-SEPT9 assay in patients with intermediate-stage hepatocellular carcinoma receiving molecular targeted agents2022
- Author(s)
  Issei Saeki, Takahiro Yamasaki, Taro Takami
- Organizer
  APASL Oncology
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] Liquid biopsy test based on methylated-SEPT9 for surveillance of nonBnonC hepatocellular carcinoma.2022
- Author(s)
  Issei Saeki, Takahiro Yamasaki, Taro Takami
- Organizer
  APASL Oncology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] Liquid biopsy test based on methylated SEPT9 for surveillance of nonBnonC hepatocellular carcinoma2022
- Author(s)
  Issei Saeki, Takahiro Yamasaki, Taro Takami
- Organizer
  APASL oncology 2022
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] 高感度メチル化SEPT9解析法によるリキッドバイオプシーは、中等度肝癌の薬物療法における予後予測バイオマーカーとなり得る2022
- Author(s)
  佐伯一成, 山﨑隆弘, 高見太郎
- Organizer
  第44回日本肝臓学会東部会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] Usefulness of liquid biopsy based on a methylated SEPT9 assay in hepatocellular carcinoma patients treated with molecular targeted agents2022
- Author(s)
  Issei Saeki, Yurika Yamauchi, Yutaka Suehiro, Hiroaki Nagano, Mototsugu Shimokawa, Taro Takami, Takahiro Yamasaki
- Organizer
  AASLD 2022
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] 肝癌診断サーベイランスにおけるEtiology別メチル化SEPT9リキッドバイオプシー検査の有用性2022
- Author(s)
  佐伯一成, 山﨑隆弘, 高見太郎
- Organizer
  第26回日本肝臓学会大会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] メチル化SEPT9は肝細胞癌治療に対する分子標的治療薬の予後予測バイオマーカーとなる2022
- Author(s)
  佐伯一成, 山﨑隆弘, 高見太郎
- Organizer
  第58回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] Usefulness of liquid biopsy based on a methylated SEPT9 assay in hepatocellular carcinoma patients treated with molecular targeted agents2022
- Author(s)
  Issei Saeki, Yurika Yamauchi, Yutaka Suehiro, Hiroaki Nagano, Mototsugu Shimokawa, Taro Takami, Takahiro Yamasaki
- Organizer
  AASLD 2022
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] SorafenibおよびLenvatinib治療中の骨格筋量の変化2021
- Author(s)
  山内由里佳, 佐伯一成, 川本大樹, 西村達朗, 田邉規和, 大野高嗣, 石川剛, 山崎隆弘, 高見太郎
- Organizer
  第44回日本肝臓学会西部会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] 肝癌分子標的治療薬に対するメチル化 SEPT9 によるリキッドバイオプシー検査の予後予測マーカーとしての可能性2021
- Author(s)
  佐伯一成、山﨑隆弘、高見太郎
- Organizer
  第44回日本肝臓学会西部会
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] Potential application of a liquid biopsy based on sensitive methylated SEPT9 as a prognostic marker in hepatocellular carcinoma patients treated with molecular targeted agents.2021
- Author(s)
  Issei Saeki, Yurika Yamauchi, Yutaka Suehiro, Hiroaki Nagano, Mototsugu Shimokawa, Taro Takami, Takahiro Yamasaki.
- Organizer
  The Liver Meeting 2021, AASLD
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] 高感度DNAメチル化解析技術を用いたリキッドバイオプシーによる肝細胞癌スクリーニングメチル化SSTとメチル化SEPT9の診断性能比較2021
- Author(s)
  山崎綾乃, 末廣寛, 星田朋美, 佐伯一成, 山内由里佳, 松本俊彦, 高見太郎, 坂井田功, 山崎隆弘
- Organizer
  第127回山口大学医学会学術講演会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] 肝癌分子標的治療薬に対するメチル化SEPT9によるリキッドバイオプシー検査の予後予測マーカーとしての可能性2021
- Author(s)
  佐伯一成, 山崎隆弘, 高見太郎
- Organizer
  第44回日本肝臓学会西部会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] Lenvatinib治療における握力と骨格筋量の関連2021
- Author(s)
  山内　由里佳、佐伯　一成、坂井田　功
- Organizer
  第107回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] 肝細胞癌に対するレンバチニブ治療におけるRECIST:SD細分化による後治療切り替えタイミングの検討2021
- Author(s)
  田邉規和、佐伯一成、山内由里佳、松田崇史、日高勲、石川剛、高見太郎、山﨑隆弘、坂井田功
- Organizer
  第57回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] Analysis of skeletal muscle changes during sorafenib or lenvatinib therapy for hepatocellular carcinoma2021
- Author(s)
  Yurika Yamauchi, Issei Saeki, Takahiro Yamasaki, Norikazu Tanabe, Taro Takami
- Organizer
  JSH International Liver Conference 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] Liquid biopsy based on sensitive methylated SEPT9 as a prognostic marker in hepatocellular carcinoma patients treated with molecular targeted agents.2021
- Author(s)
  Issei Saeki, Yurika Yamauchi, Yutaka Suehiro, Hiroaki Nagano, Mototsugu Shimokawa, Taro Takami, Takahiro Yamasaki.
- Organizer
  JSH International Liver Conference 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] 肝予備能による進行肝癌の治療戦略2021
- Author(s)
  佐伯一成、田邉規和、高見太郎、山﨑隆弘、坂井田　功
- Organizer
  第115回日本消化器病学会中国支部例会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] SorafenibおよびLenvatinib治療中の骨格筋量の変化2021
- Author(s)
  内　由里佳、佐伯　一成、川本　大樹、西村　達朗、田邉　規和、大野　高嗣、石川　剛、山﨑　隆弘、高見　太郎
- Organizer
  第44回日本肝臓学会西部会
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] メチル化SEPT9定量は肝癌分子標的薬において予後予測バイオマーカーとなる可能性がある2021
- Author(s)
  佐伯一成、山﨑隆弘、末廣寛、山内由里佳、田邉規和、松田崇史、日高勲、石川剛、高見太郎、坂井田功
- Organizer
  第56回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] 肝細胞癌に対する3次治療以上の逐次治療可能予測因子2021
- Author(s)
  田邉規和, 佐伯一成, 川本大樹, 山内由里佳, 西村達朗, 大野高嗣, 石川剛, 山崎隆弘, 高見太郎
- Organizer
  第44回日本肝臓学会西部会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] 肝細胞癌に対するSorafenibとLenvatinib治療中の骨格筋量の変化の違い2021
- Author(s)
  山内由里佳、佐伯一成、佐々木嶺、田邉規和、大野高嗣、松田崇史、日高勲、石川剛、高見太郎、山﨑隆弘、坂井田　功、
- Organizer
  第56回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] Potential application of a liquid biopsy based on sensitive methylated SEPT9 for a prognostic marker in hepatocellular carcinoma patients treated with molecular targeted agent2021
- Author(s)
  Issei Saeki, Yurika Yamauchi, Yutaka Suehiro, Mototsugu Shimokawa, Hiroaki Nagano, Takahiro Yamasaki, Taro Takami
- Organizer
  AASLD2021:The Liver Meeting
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] 分子標的治療薬投与中の骨格筋量変化ーSorafenibとlenvatinibの比較ー2021
- Author(s)
  山内由里佳、佐伯一成、田邉規和、大野高嗣、石川剛、高見太郎、山﨑隆弘、坂井田功
- Organizer
  第24回日本肝がん分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] Liquid biopsy based on sensitive methylated SEPT9 as a prognostic marker in hepatocellular carcinoma patients treated with molecular targeted agents2021
- Author(s)
  Issei Saeki, Yurika Yamauchi, Yutaka Suehiro, Hiroaki Nagano, Mototsugu Shimokawa, Taro Takami, Takahiro Yamasaki
- Organizer
  JSH International Liver Conference 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] Transcatheter Arterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma (TACTICS-L) in Japan: Interim analysis.2021
- Author(s)
  Issei Saeki, Toru Ishikawa, Kazuomi Ueshima, et al.
- Organizer
  APPLE Meeting 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] Analysis of skeletal muscle changes during sorafenib or lenvatinib therapy for hepatocellular carcinoma.2021
- Author(s)
  Yurika Yamauchi, Issei Saeki, Takahiro Yamasaki, Norikazu Tanabe, Taro Takami.
- Organizer
  JSH International Liver Conference 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] Impact of skeletal muscle volume in patients with intermediate-stage hepatocellular carcinoma (HCC) receiving sorafenib: A comparison with advanced HCC patients.2021
- Author(s)
  Issei Saeki, Takahiro Yamasaki, Yurika Yamauchi, Tomokazu Kawaoka, Shinsuke Uchikawa, Akira Hiramatsu, Hiroshi Aikata, Kazufumi Kobayashi, Takayuki Kondo, Sadahisa Ogasawara, Tetsuhiro Chiba, Kazuaki Chayama, Naoya Kato, Isao Sakaida, Taro Takami.
- Organizer
  APASL Oncology　2021
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] Impact of skeletal muscle volume in patients with intermediate-stage hepatocellular carcinoma (HCC) receiving sorafenib: A comparison with advanced HCC patients2021
- Author(s)
  Issei Saeki , Takahiro Yamasaki, Yurika Yamauchi, Tomokazu Kawaoka, Shinsuke Uchikawa, Akira Hiramatsu, Hiroshi Aikata, Kazufumi Kobayashi, Takayuki Kondo 4, Sadahisa Ogasawara, Tetsuhiro Chiba, Kazuaki Chayama, Naoya Kato, Isao Sakaida, Taro Takami
- Organizer
  APASL Oncology 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] 肝内脂肪沈着は腹囲により推定可能である2021
- Author(s)
  山内　由里佳、佐伯　一成、中島　小百合、松尾　亜矢、西川　寛子、田邉　規和、日髙　勲、高見　太郎、山﨑　隆弘、坂井田　功
- Organizer
  第94回日本超音波医学会
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] 肝細胞癌に対する 3次治療以上の逐次治療可能予測因子2021
- Author(s)
  田邉規和、佐伯一成、川本大樹、山内由里佳、西村達朗、大野高嗣、石川　剛、山﨑隆弘、高見太郎
- Organizer
  第44回日本肝臓学会西部会
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] Lenvatinib治療は、Sorafenib治療よりChild-Pugh A・mALBI2bの進行肝癌症例の肝機能を悪化させる2021
- Author(s)
  佐伯一成、山内由里佳、田邉規和、大野高嗣、石川剛、高見太郎、山﨑隆弘、坂井田功
- Organizer
  第24回日本肝がん分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] AFP responseはレンバチニブの肝細胞癌治療における奏効予測因子である2020
- Author(s)
  佐伯一成, 厚東由里佳, 佐々木嶺, 大野高嗣, 岩本拓也, 日高勲, 石川剛, 高見太郎, 山﨑隆弘, 坂井田功
- Organizer
  第56回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] 肝癌合併慢性肝疾患患者におけるエネルギー代謝障害2020
- Author(s)
  厚東由里佳, 佐伯一成, 大野高嗣, 岩本拓也, 日高勲, 石川剛, 高見太郎, 山﨑隆弘, 坂井田功
- Organizer
  第56回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] 肝硬度はレンバチニブの奏効因子である2020
- Author(s)
  佐伯　一成，藤井　彩乃，松尾　亜矢，西川　寛子，日高　勲，高見　太郎，山﨑　隆弘，坂井田　功
- Organizer
  日本超音波医学会第93回学術集会
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] AFP responseはレンバチニブの肝細胞癌治療における奏効予測因子である2020
- Author(s)
  佐伯一成, 厚東由里佳, 佐々木嶺, 大野高嗣, 岩本拓也, 日高勲, 石川剛, 高見太郎, 山﨑隆弘, 坂井田功
- Organizer
  第106回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] 画像奏効と肝予備能による進行肝癌の治療戦略2020
- Author(s)
  佐伯一成, 山﨑隆弘, 坂井田功
- Organizer
  第24回日本肝臓学会大会
- Data Source
  KAKENHI-PROJECT-20K08332
[Presentation] 骨格筋量は肝細胞癌に対するSorafenibの個別化医療のひとつのファクターである2020
- Author(s)
  佐伯　一成、山﨑　隆弘、厚東　由里佳、河岡　友和、相方　浩、小笠原　定久、近藤　孝行、加藤　直也、茶山　一彰、坂井田　功
- Organizer
  第56回　日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] Treatment strategy using body composition for advanced hepatocellular carcinoma: hepatic arterial infusion chemotherapy2019
- Author(s)
  Issei Saeki, Takahiro Yamasaki,　Yurika Kotoh, Taro Takami, Isao Sakaida
- Organizer
  13th Annual Conference of the International Liver Cancer Association
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] レンバチニブの初期使用経験―山口県多施設共同研究2019
- Author(s)
  佐伯一成、前田雅喜、山崎隆弘、坂井田功
- Organizer
  第19回肝がん分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] 高感度SEPT9メチル化解析法による肝癌診断の有用性2019
- Author(s)
  佐伯一成，山﨑隆弘，坂井田功
- Organizer
  第43回日本肝臓学会西部会
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] レンバチニブ導入後の腫瘍マーカーの推移と画像評価―山口県多施設共同研究2019
- Author(s)
  佐伯　一成，厚東　由里佳, 山﨑　隆弘，坂井田　功
- Organizer
  第20回肝がん分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] 体組成評価は進行肝癌治療ストラテジーのバイオマーカーである：動注化学療法 vs. ソラフェニブ2019
- Author(s)
  佐伯　一成，山﨑　隆弘，坂井田　功
- Organizer
  第55回日本肝がん研究会
- Data Source
  KAKENHI-PROJECT-19K17463
[Presentation] 超音波検査を用いた仮想SAF systemによるNASH診断2018
- Author(s)
  佐伯一成, 日高勲, 岡本健志, 山崎隆弘, 坂井田功
- Organizer
  第39回日本肥満学会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] ソラフェニブ治療後の進行肝癌におけるレゴラフェニブの位置づけーPD時期に着目してー2018
- Author(s)
  佐伯一成、山﨑隆弘、前田雅喜、坂井田　功
- Organizer
  第18回日本肝がん分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 肝癌診療におけるサルコペニア評価の問題点2018
- Author(s)
  佐伯一成, 山崎隆弘, 坂井田功
- Organizer
  第54回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 門脈圧亢進症症例に対する部分脾動脈塞栓術の効果と門脈血流速の変化との関係性の検討2018
- Author(s)
  福井悠美, 佐伯一成, 日高勲, 高見太郎, 山崎隆弘, 坂井田功
- Organizer
  日本超音波医学会第91回学術集会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 超音波検査による仮想NAS(NASH activity score)2018
- Author(s)
  佐伯一成, 福井悠美, 日高勲, 高見太郎, 坂井田功, 山崎隆弘
- Organizer
  日本超音波医学会第91回学術集会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] Impact of body composition in patients with advanced hepatocellular carcinoma: sorafenib versus hepatic arterial infusion chemotherapy2018
- Author(s)
  Issei Saeki, Takahiro Yamasaki, Masaki Maeda, Taro Takami, Isao Sakaida
- Organizer
  12th ILCA Annual Conference
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 肝細胞癌に対するTACE治療の早期治療効果方法の検討2018
- Author(s)
  前田雅喜、佐伯一成、高見太郎、山﨑隆弘、坂井田　功
- Organizer
  第54回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 体組成評価及びACTHスコアによる進行肝癌治療アルゴリズム：肝動注とソラフェニブ治療との棲み分け2018
- Author(s)
  佐伯一成、前田雅喜、高見太郎、山﨑隆弘、坂井田　功
- Organizer
  第54回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 当院における肝硬変の実態と経時的変化の検討2018
- Author(s)
  久永拓郎, 高見太郎, 前田雅喜, 岩本拓也, 佐伯一成, 松本俊彦, 日高勲, 丸本芳雄, 石川剛, 山崎隆弘, 坂井田功
- Organizer
  第54回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 進行肝細胞癌に対してソラフェニブが一旦中止となるも、その後再開しレゴラフェニブを導入し奏功した1例2018
- Author(s)
  前田雅喜、佐伯一成、高見太郎、山﨑隆弘、坂井田　功
- Organizer
  第18回日本肝がん分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 進行肝癌治療ストラテジー：肝動注からソラフェニブ治療へのConversionは有用である2017
- Author(s)
  佐伯一成、前田雅喜、高見太郎、山﨑隆弘、坂井田功
- Organizer
  第16回日本肝がん分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 進行肝癌の治療戦略においてCT検査によるサルコペニア評価が有用である2017
- Author(s)
  佐伯一成、山﨑隆弘、坂井田功
- Organizer
  第53回　日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] Multicenter study assesing complications of radiofrequency ablation for hepatocellular carcinoma: An analysis of 10,855 patients between 2011 and 20152017
- Author(s)
  Takahiro Yamasak, Issei Saeki, Masaki Maeda, Takami Taro, Isao Sakaida
- Organizer
  11th ILCA Annual Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 肝硬変患者に対する肝疾患専門医療機関の早期介入の有用性2017
- Author(s)
  久永拓郎、山﨑隆弘、前田雅喜、岩本拓也、佐伯一成、松本俊彦、日高　勲、丸本芳雄、石川　剛、高見太郎、坂井田　功
- Organizer
  第53回　日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 肝内胆管浸潤を伴う肝細胞癌に対してDEB-TACEを行った後に胆道出血を来した一例2017
- Author(s)
  仁志麻衣子、佐伯一成、前田雅喜、日高勲、高見太郎、山﨑隆弘、坂井田功
- Organizer
  第53回　日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 進行肝癌の治療戦略決定においてサルコペニアと内臓脂肪評価が有用である2017
- Author(s)
  佐伯一成、前田雅喜、岩本拓也、日高　勲、石川　剛、高見太郎、山﨑隆弘、坂井田　功
- Organizer
  第53回　日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] "Iron chelator therapy for Hepatocellular Carcinoma 肝がんに対する鉄キレート剤治療 "2017
- Author(s)
  Takahiro Yamasaki, Issei Saeki, Isao Sakaida
- Organizer
  第15回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] Non-sarcopenia with high visceral fat area as a favorable prognostic factor in patients with advanced hepatocellular carcinoma treated with sorafenib2017
- Author(s)
  Issei Saeki, TakahiroYamasaki, MasakiMaeda, Taro Takami, and Isao Sakaida
- Organizer
  11th ILCA Annual Conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 体組成評価及びACTHスコアによる進行肝癌治療アルゴリズムの提唱2017
- Author(s)
  佐伯一成、山﨑隆弘、坂井田功
- Organizer
  第42回　日本肝臓学会西部会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 多施設研究による肝癌ラジオ波焼灼療法の合併症：2010年から2015年までの10,855症例での解析2017
- Author(s)
  前田雅喜、佐伯一成、山﨑隆弘、坂井田功
- Organizer
  第53回　日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 体組成評価は、進行肝癌に対する肝動注とソラフェニブ治療の棲み分けを可能とする2017
- Author(s)
  佐伯一成、山﨑隆弘、坂井田功
- Organizer
  第21回　日本肝臓学会大会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 進行肝癌に対するソラフェニブ治療は内臓脂肪評価が蓄積した非サルコペニア症例が有効である2017
- Author(s)
  佐伯一成、前田雅喜、高見太郎、山﨑隆弘、坂井田功
- Organizer
  第108回　日本消化器病学会中国支部例会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] DAA治療後のHCC発症抑制効果の検討とSVR後発癌の特徴2017
- Author(s)
  日高勲、佐伯一成、前田雅喜、山﨑隆弘、坂井田功
- Organizer
  第53回　日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] Effects of iron chelator, deferasirox, on hepatocellular carcinoma in basic and clinical studies.2016
- Author(s)
  Issei Saeki, Takahiro Yamasaki, Naoki Yamamoto, Koichi Fujisawa, Toshihiko Matsumoto, Taro Takami, Isao Sakaida.
- Organizer
  10th ILCA Annual Conference
- Place of Presentation
  Vancouver, Canada
- Year and Date
  2016-09-09
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] Usefulness of ACTH (Assessment for Continuous Treatment with Hepatic arterial infusion chemotherapy) score in patients with advanced hepatocellular carcinoma.2016
- Author(s)
  Issei Saeki, Takahiro Yamasaki, Masaki Maeda, Takuro Hisanaga, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Isao Sakaida.
- Organizer
  The 12th JSH single topic conference.
- Place of Presentation
  石川兼金沢市（ホテル日航金沢）
- Year and Date
  2016-09-22
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] 進行肝細胞癌に対する経口鉄キレート剤の治療戦略2016
- Author(s)
  佐伯一成、山本直樹、坂井田　功.
- Organizer
  第52回日本肝臓学会総会
- Place of Presentation
  千葉県千葉市（ホテルニューオータニ幕張）
- Year and Date
  2016-05-19
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] ACTH(Assessment for Continuous Treatment with HAIC)スコアは動注化学療法の早期評価に有効である2016
- Author(s)
  佐伯一成、前田雅喜、日高　勲、高見太郎、山﨑隆弘、坂井田　功.
- Organizer
  第52回日本肝癌研究会
- Place of Presentation
  東京都港区（虎ノ門ヒルズフォーラム）
- Year and Date
  2016-07-01
- Data Source
  KAKENHI-PROJECT-16H05287
[Presentation] Evaluation of ACTH (Assessment for Continuous Treatment with Hepatic arterial infusion chemotherapy) score in patients with advanced hepatocellular carcinoma.2016
- Author(s)
  Takahiro Yamasaki, Issei Saeki, Masaki Maeda, Takuro Hisanaga, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Isao Sakaida.
- Organizer
  10th ILCA Annual Conference
- Place of Presentation
  Vancouver, Canada
- Year and Date
  2016-09-09
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05287

1. YAMASAKI Takahiro (00304478)

# of Collaborated Projects: 3 results

# of Collaborated Products: 66 results
2. 高見太郎 (60511251)

# of Collaborated Projects: 2 results

# of Collaborated Products: 66 results
3. 末廣寛 (40290978)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. 藤澤浩一 (00448284)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
5. 山本直樹 (90448283)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
6. 山口奈津 (40450671)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 田邉剛 (80260678)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 中上裕有樹 (30843304)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 石川剛 (20569305)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
10. 田邉規和 (60886448)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. SUEHIRO Yutaka

# of Collaborated Projects: 0 results

# of Collaborated Products: 8 results
12. 永野浩昭

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
13. 徳光幸生

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
14. 岩本拓也

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
15. 松本俊彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 4 results
16. 松隈聰

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Saeki Issei 佐伯 一成

Research Projects

Research Products

Co-Researchers

早期肝癌発見を可能とするリキッドバイオプシー検査体制の構築

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Establishment of a Novel Screening Test for Diagnosing Hepatocellular Carcinoma based on a Sensitive DNA Methylation Assay

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

生活習慣病に合併する肝癌の早期診断マーカーの開発：血中細胞外小胞の解析

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Challenging for the management of HCC using novel liquid biopsy testPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Effects of a novel oral iron chelator on refractory digestive system cancers

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Double cancer of primary hepatic angiosarcoma and hepatocellular carcinoma treated with atezolizumab plus bevacizumab. Hepatol Res. 2023 Feb 24.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Impact of skeletal muscle volume on patients with BCLC stage-B hepatocellular carcinoma undergoing sorafenib therapy2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A combination of liver stiffness and international normalized ratio is an ideal prognostic predictor of portosystemic shunt occlusion in patients with portal hypertension2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Screening for portopulmonary hypertension using computed tomography-based measurements of the main pulmonary artery and ascending aorta diameters in patients with portal hypertension.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification2021

Author(s)

Journal Title

DOI

NAID

ISSN

Year and Date

Language

Data Source

[Journal Article] Successful Management With Dual Therapy of Lenvatinib and Macitentan for HCC With Portopulmonary Hypertension2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 高感度DNAメチル化解析技術を用いたリキッドバイオプシーによる肝細胞癌スクリーニング : メチル化SSTとメチル化SEPT9の診断性能比較2021

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenism2021

Author(s)

Saeki Issei 佐伯一成